The European Commission approved of 3-fucosyllactose as a novel food ingredient, marking a milestone for improving market access of a broader range of HMOs.
The Spilanthes acmella extract was associated with significant increases in mean testosterone levels, muscle mass, and self-reported sexual satisfaction.
The first-of-its-kind state bill, which bans the sale of “weight loss” and “muscle building” supplements to minors, is slated to go into effect in April 2024.